[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global MicroRNA Market Size study, by Product (Instruments, Kits & Reagent), by Application (Isolation & Purification, Detection & Quantification, Disease Diagnostics, Others), by End-Use (Pharma & Biotech Companies, Academic & Research Institutes, Healthcare Facilities, Others) and Regional Forecasts 2020-2027

March 2021 | 200 pages | ID: G17C790E8D13EN
Bizwit Research & Consulting LLP

US$ 4,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Global MicroRNA Market is valued at approximately USD 714 million in 2019 and is anticipated to grow with a healthy growth rate of more than 19.8% over the forecast period 2020-2027. MicroRNA, or miRNA, is a minor single-trapped non-coding RNA molecule, usually found in animals, plants, and some viruses, that regulates the gene expression post-transcriptionally. miRNAs typically function through base-pairing with corresponding sequences within mRNA molecules. More often, they are well-known for their benefits in treatment and diagnosis of several diseases, including cancer, neurological disorder, infectious diseases, liver diseases, metabolic diseases, and coronary heart diseases. For example, in the case of cancer, the overexpressed miRNA are frequently studied oncogenes. Few of them are expressed in extreme low level in specific cancerous cells and typically helps in preventing tumor developments. Therefore, the high presence of cancer patients in the region driving the demand for MicroRNA market. For instance, the International Agency for Research on Cancer (IARC) found that the prevalence rate and mortality cases of cancer have been alarming in the present scenario, owing to the rapid population growth and socio-economic development. In 2018, around 18.1 million new cancer cases were reported across the world and is anticipated to reach almost 27.5 million new cancer cases by 2040. This increased prevalence of cancer and other chronic diseases may result in the high adoption of miRNA market around the world. In addition, the introduction of new RNA technology for treating genetic disorders is further fuelling the demand of overall market. For instance, in August 2018, BioNTech AG has collaborated with Pfizer to develop Messenger RNA (mRNA)-based influenza vaccines. These stimulating strategic collaborations has led to ground-breaking developments in the RNA-based therapeutics field. This, in turn, is likely to strengthen the demand for MicroRNA, globally. However, the high cost related to microRNA kits and other products, coupled with limited availability of life science infrastructure in emerging countries are the few factors impeding the market growth over the forecast period of 2020-2027.

The regional analysis of the global MicroRNA market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising awareness about the benefits of MicroRNA among life science-based institutions, along with the growing number of market vendors in the region. Whereas, Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as growing prevalence of chronic diseases, such as cancer and cardiovascular, along with growing spending on development of biotechnology infrastructure in emerging countries, such as China and India, are the few factors creating lucrative growth opportunities for the MicroRNA market in the region.

Major market player included in this report are:
Qiagen N.V.
Thermo Fisher Scientific
BioVendor
Takara Bio Inc.
Merck KGaA
NanoString Technologies, Inc.
Heim Biotek
GeneCopoeia, Inc.
Horizon Discovery Group Co.
Synlogic, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Instruments
Reagent

By Application:
Isolation & Purification
Detection & Quantification
Disease Diagnostics
Others

By End-Use:
Pharma & Biotech Companies
Academic & Research Institutes
Healthcare Facilities
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global MicroRNA Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million)
  1.2.1. MicroRNA Market, by Region, 2018-2027 (USD Million)
  1.2.2. MicroRNA Market, by Product, 2018-2027 (USD Million)
  1.2.3. MicroRNA Market, by Application, 2018-2027 (USD Million)
  1.2.4. MicroRNA Market, by End-Use, 2018-2027 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

CHAPTER 2. GLOBAL MICRORNA MARKET DEFINITION AND SCOPE

2.1. Objective of the Study
2.2. Market Definition & Scope
  2.2.1. Scope of the Study
  2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

CHAPTER 3. GLOBAL MICRORNA MARKET DYNAMICS

3.1. MicroRNA Market Impact Analysis (2018-2027)
  3.1.1. Market Drivers
  3.1.2. Market Challenges
  3.1.3. Market Opportunities

CHAPTER 4. GLOBAL MICRORNA MARKET INDUSTRY ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
  4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
  4.2.1. Political
  4.2.2. Economical
  4.2.3. Social
  4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL MICRORNA MARKET, BY PRODUCT

5.1. Market Snapshot
5.2. Global MicroRNA Market by Product, Performance - Potential Analysis
5.3. Global MicroRNA Market Estimates & Forecasts by Product 2017-2027 (USD Million)
5.4. MicroRNA Market, Sub Segment Analysis
  5.4.1. Instruments
  5.4.2. Kits & Reagents

CHAPTER 6. GLOBAL MICRORNA MARKET, BY APPLICATION

6.1. Market Snapshot
6.2. Global MicroRNA Market by Application, Performance - Potential Analysis
6.3. Global MicroRNA Market Estimates & Forecasts by Application 2017-2027 (USD Million)
6.4. MicroRNA Market, Sub Segment Analysis
  6.4.1. Isolation & Purification
  6.4.2. Detection & Quantification
  6.4.3. Disease Diagnostics
  6.4.4. Others

CHAPTER 7. GLOBAL MICRORNA MARKET, BY END-USE

7.1. Market Snapshot
7.2. Global MicroRNA Market by End-Use - Potential Analysis
7.3. Global MicroRNA Market Estimates & Forecasts by End-Use 2017-2027 (USD Million)
7.4. MicroRNA Market, Sub Segment Analysis
  7.4.1. Pharma & Biotech Companies
  7.4.2. Academic & Research Institutes
  7.4.3. Healthcare Facilities
  7.4.4. Others

CHAPTER 8. GLOBAL MICRORNA MARKET, REGIONAL ANALYSIS

8.1. MicroRNA Market, Regional Market Snapshot
8.2. North America MicroRNA Market
  8.2.1. U.S. MicroRNA Market
    8.2.1.1. Product breakdown estimates & forecasts, 2017-2027
    8.2.1.2. Application breakdown estimates & forecasts, 2017-2027
    8.2.1.3. End-Use breakdown estimates & forecasts, 2017-2027
  8.2.2. Canada MicroRNA Market
8.3. Europe MicroRNA Market Snapshot
  8.3.1. U.K. MicroRNA Market
  8.3.2. Germany MicroRNA Market
  8.3.3. France MicroRNA Market
  8.3.4. Spain MicroRNA Market
  8.3.5. Italy MicroRNA Market
  8.3.6. Rest of Europe MicroRNA Market
8.4. Asia-Pacific MicroRNA Market Snapshot
  8.4.1. China MicroRNA Market
  8.4.2. India MicroRNA Market
  8.4.3. Japan MicroRNA Market
  8.4.4. Australia MicroRNA Market
  8.4.5. South Korea MicroRNA Market
  8.4.6. Rest of Asia Pacific MicroRNA Market
8.5. Latin America MicroRNA Market Snapshot
  8.5.1. Brazil MicroRNA Market
  8.5.2. Mexico MicroRNA Market
8.6. Rest of The World MicroRNA Market

CHAPTER 9. COMPETITIVE INTELLIGENCE

9.1. Top Market Strategies
9.2. Company Profiles
  9.2.1. Qiagen N.V.
    9.2.1.1. Key Information
    9.2.1.2. Overview
    9.2.1.3. Financial (Subject to Data Availability)
    9.2.1.4. Product Summary
    9.2.1.5. Recent Developments
  9.2.2. Thermo Fisher Scientific
  9.2.3. BioVendor
  9.2.4. Takara Bio Inc.
  9.2.5. Merck KGaA
  9.2.6. NanoString Technologies, Inc.
  9.2.7. Heim Biotek
  9.2.8. GeneCopoeia, Inc.
  9.2.9. Horizon Discovery Group Co.
  9.2.10. Synlogic, Inc.

CHAPTER 10. RESEARCH PROCESS

10.1. Research Process
  10.1.1. Data Mining
  10.1.2. Analysis
  10.1.3. Market Estimation
  10.1.4. Validation
  10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES

TABLE 1. Global MicroRNA market, report scope
TABLE 2. Global MicroRNA market estimates & forecasts by region 2017-2027 (USD Million)
TABLE 3. Global MicroRNA market estimates & forecasts by Product 2017-2027 (USD Million)
TABLE 4. Global MicroRNA market estimates & forecasts by Services 2017-2027 (USD Million)
TABLE 5. Global MicroRNA market estimates & forecasts by Application 2017-2027 (USD Million)
TABLE 6. Global MicroRNA market estimates & forecasts by End-Use 2017-2027 (USD Million)
TABLE 7. Global MicroRNA market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 8. Global MicroRNA market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 9. Global MicroRNA market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 10. Global MicroRNA market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 11. Global MicroRNA market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 12. Global MicroRNA market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 13. Global MicroRNA market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 14. Global MicroRNA market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 15. Global MicroRNA market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 16. Global MicroRNA market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 17. Global MicroRNA market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 18. Global MicroRNA market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 19. Global MicroRNA market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 20. Global MicroRNA market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 21. Global MicroRNA market by segment, estimates & forecasts, 2017-2027 (USD Million)
TABLE 22. Global MicroRNA market by region, estimates & forecasts, 2017-2027 (USD Million)
TABLE 23. U.S. MicroRNA market estimates & forecasts, 2017-2027 (USD Million)
TABLE 24. U.S. MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 25. U.S. MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 26. Canada MicroRNA market estimates & forecasts, 2017-2027 (USD Million)
TABLE 27. Canada MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 28. Canada MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 29. UK MicroRNA market estimates & forecasts, 2017-2027 (USD Million)
TABLE 30. UK MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 31. UK MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 32. Germany MicroRNA market estimates & forecasts, 2017-2027 (USD Million)
TABLE 33. Germany MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 34. Germany MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 35. France MicroRNA market estimates & forecasts, 2017-2027 (USD Million)
TABLE 36. France MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 37. France MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 38. Spain MicroRNA market estimates & forecasts, 2017-2027 (USD Million)
TABLE 39. Spain MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 40. Spain MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 41. Italy MicroRNA market estimates & forecasts, 2017-2027 (USD Million)
TABLE 42. Italy MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 43. Italy MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 44. ROE MicroRNA market estimates & forecasts, 2017-2027 (USD Million)
TABLE 45. ROE MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 46. ROE MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 47. China MicroRNA market estimates & forecasts, 2017-2027 (USD Million)
TABLE 48. China MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 49. China MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 50. India MicroRNA market estimates & forecasts, 2017-2027 (USD Million)
TABLE 51. India MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 52. India MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 53. Japan MicroRNA market estimates & forecasts, 2017-2027 (USD Million)
TABLE 54. Japan MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 55. Japan MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 56. Australia MicroRNA market estimates & forecasts, 2017-2027 (USD Million)
TABLE 57. Australia MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 58. Australia MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 59. South Korea MicroRNA market estimates & forecasts, 2017-2027 (USD Million)
TABLE 60. South Korea MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 61. South Korea MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 62. ROPAC MicroRNA market estimates & forecasts, 2017-2027 (USD Million)
TABLE 63. ROPAC MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 64. ROPAC MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 65. Brazil MicroRNA market estimates & forecasts, 2017-2027 (USD Million)
TABLE 66. Brazil MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 67. Brazil MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 68. Mexico MicroRNA market estimates & forecasts, 2017-2027 (USD Million)
TABLE 69. Mexico MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 70. Mexico MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 71. ROLA MicroRNA market estimates & forecasts, 2017-2027 (USD Million)
TABLE 72. ROLA MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 73. ROLA MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 74. ROW MicroRNA market estimates & forecasts, 2017-2027 (USD Million)
TABLE 75. ROW MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 76. ROW MicroRNA market estimates & forecasts by segment 2017-2027 (USD Million)
TABLE 77. List of secondary sources, used in the study of global MicroRNA market
TABLE 78. List of primary sources, used in the study of global MicroRNA market
TABLE 79. Years considered for the study
TABLE 80. Exchange rates considered
LIST OF FIGURES

FIG 1. Global MicroRNA market, research methodology
FIG 2. Global MicroRNA market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global MicroRNA market, key trends 2019
FIG 5. Global MicroRNA market, growth prospects 2020-2027
FIG 6. Global MicroRNA market, porters 5 force model
FIG 7. Global MicroRNA market, pest analysis
FIG 8. Global MicroRNA market, value chain analysis
FIG 9. Global MicroRNA market by segment, 2017 & 2027 (USD Million)
FIG 10. Global MicroRNA market by segment, 2017 & 2027 (USD Million)
FIG 11. Global MicroRNA market by segment, 2017 & 2027 (USD Million)
FIG 12. Global MicroRNA market by segment, 2017 & 2027 (USD Million)
FIG 13. Global MicroRNA market by segment, 2017 & 2027 (USD Million)
FIG 14. Global MicroRNA market by segment, 2017 & 2027 (USD Million)
FIG 15. Global MicroRNA market by segment, 2017 & 2027 (USD Million)
FIG 16. Global MicroRNA market by segment, 2017 & 2027 (USD Million)
FIG 17. Global MicroRNA market, regional snapshot 2017 & 2027
FIG 18. North America MicroRNA market 2017 & 2027 (USD Million)
FIG 19. Europe MicroRNA market 2017 & 2027 (USD Million)
FIG 20. Asia-Pacific MicroRNA market 2017 & 2027 (USD Million)
FIG 21. Latin America MicroRNA market 2017 & 2027 (USD Million)
FIG 22. Global MicroRNA market, company market share analysis (2019)


More Publications